Influenza News and Research

Latest Influenza News and Research

Nanozyme breakthrough offers new hope for viral pneumonia treatment

A recent study in Nature Materials introduces an inhalable nanozyme treatment for viral pneumonia, showing promising results in reducing inflammation and viral load in various mouse models. The nanozyme, CeTA-K1tkP, demonstrates broad-spectrum effects and biocompatibility, offering a potential new approach to treating pneumonia and other inflammatory conditions.

3 Dec 2024

Polypurine hairpins found to effectively halt SARS-CoV-2 replication

A study led by the University of Barcelona and the Spanish National Research Council's Institute for Advanced Chemistry of Catalonia (IQAC - CSIC) presents a new therapeutic tool capable of inhibiting the proliferation of the SARS-CoV-2 virus that causes COVID-19.

3 Dec 2024

Pregnancy strengthens immune defense against flu, study finds

McGill University scientists have discovered that pregnancy may trigger a natural immunity to boost protection against severe flu infection.

2 Dec 2024

Reinstating masking curbs hospital viral outbreaks, study confirms

Researchers investigate how changes in hospital policies for SARS-CoV-2 testing and masking have influenced hospital-acquired respiratory viral infections.

1 Dec 2024

DNA-based nanorobotic hand could block viruses and enable rapid diagnostics

A tiny, four-fingered "hand" folded from a single piece of DNA can pick up the virus that causes COVID-19 for highly sensitive rapid detection and can even block viral particles from entering cells to infect them, University of Illinois Urbana-Champaign researchers report.

27 Nov 2024

A toddler got a nasal swab test but left before seeing a doctor. The bill was $445.

Ryan Wettstein Nauman was inconsolable one evening last December. After being put down for bed, the 3-year-old from Peoria, Illinois, just kept crying and crying and crying, and nothing would calm her down.

27 Nov 2024

Researchers explore the power of podcasts in fighting infectious disease misinformation

With legacy media cutting staff in the face of unprecedented financial challenges and critical science and health information scattered among unfamiliar digital platforms, how can people keep up with medical issues that might affect them?

27 Nov 2024

WHO and partners announce grants to boost pathogen genomic surveillance

The World Health Organization (WHO) and partners announced 10 projects that will receive almost US$ 2 million in grants to improve capacities in pathogen genomic surveillance.

26 Nov 2024

Advanced diagnostic kit developed for detecting highly pathogenic H5N1 avian influenza virus

The Diagnostics Development Hub (DxD Hub), a national platform hosted by the Agency for Science, Technology and Research (A*STAR), Singapore, in collaboration with the National Institute for Environmental Studies (NIES), Japan, and the A*STAR Bioinformatics Institute (A*STAR BII), has successfully developed Steadfast, an advanced diagnostic kit for detecting the highly pathogenic H5N1 Avian Influenza Virus (AIV).

22 Nov 2024

Cigarette smoke can induce disordered oropharyngeal microbiota that aggravates flu severity

New research has shown that cigarette smoke can induce disordered oropharyngeal microbiota that aggravates the severity of influenza A virus infection.

20 Nov 2024

Electronic nudges boost flu vaccination rates among heart attack survivors

An electronic letter, or nudge, highlighting the cardiovascular benefits of influenza vaccines improved vaccination rates among more than 2 million adults—with a greater impact on those who have had a heart attack—across three clinical trials spanning the most-recent, two consecutive influenza seasons in Denmark.

18 Nov 2024

New insights into how IFITM3 protein protects against severe flu

Researchers have identified new roles for a protein long known to protect against severe flu infection – among them, raising the minimum number of viral particles needed to cause sickness.

15 Nov 2024

FasL inhibitor speeds recovery and reduces mortality in severe COVID-19 patients

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery of COVID-19 patients and reduced mortality.

14 Nov 2024

HEPA air purifiers fall short in cutting respiratory infections in aged-care facilities

Research on HEPA-14 air purifiers in aged care reveals no significant impact on respiratory infections, though initial phase results suggest potential benefits.

13 Nov 2024

Inequities in COVID-19 vaccination coverage for older adults highlighted in global study

Researchers provide a global overview of COVID-19 vaccination programs among the elderly.

13 Nov 2024

Next-generation metagenomic sequencing test quickly detects any kind of pathogen

Next-generation metagenomic sequencing test developed at UCSF proves its effectiveness in quickly diagnosing almost any kind of pathogen.

12 Nov 2024

Limited impact of prenatal COVID-19 exposure on child neurodevelopmental outcomes

Research shows prenatal exposure to SARS-CoV-2 linked to slight regulatory behavior improvements in infants, but no significant neurodevelopmental impacts.

12 Nov 2024

Seasonal influenza adapted and evolved during the COVID-19 pandemic

Although travel restrictions and social measures during the COVID-19 pandemic led to a dramatic global drop in seasonal influenza cases, certain influenza lineages in specific regions kept the virus circulating and evolving, according to a new study.

7 Nov 2024

Study reveals how COVID-19 affected the spread and evolution of seasonal influenza

Seasonal influenza epidemics impose substantial burdens on healthcare systems and cause >5 million hospitalizations of adults each year.

7 Nov 2024

WHO study names top pathogens in need of new vaccines

A new World Health Organization (WHO) study published today in eBioMedicine names 17 pathogens that regularly cause diseases in communities as top priorities for new vaccine development.

5 Nov 2024

Influenza News and Research

Latest Influenza News and Research

Nanozyme breakthrough offers new hope for viral pneumonia treatment

Polypurine hairpins found to effectively halt SARS-CoV-2 replication

Pregnancy strengthens immune defense against flu, study finds

Reinstating masking curbs hospital viral outbreaks, study confirms

DNA-based nanorobotic hand could block viruses and enable rapid diagnostics

A toddler got a nasal swab test but left before seeing a doctor. The bill was $445.

Researchers explore the power of podcasts in fighting infectious disease misinformation

WHO and partners announce grants to boost pathogen genomic surveillance

Advanced diagnostic kit developed for detecting highly pathogenic H5N1 avian influenza virus

Cigarette smoke can induce disordered oropharyngeal microbiota that aggravates flu severity

Electronic nudges boost flu vaccination rates among heart attack survivors

New insights into how IFITM3 protein protects against severe flu

FasL inhibitor speeds recovery and reduces mortality in severe COVID-19 patients

HEPA air purifiers fall short in cutting respiratory infections in aged-care facilities

Inequities in COVID-19 vaccination coverage for older adults highlighted in global study

Next-generation metagenomic sequencing test quickly detects any kind of pathogen

Limited impact of prenatal COVID-19 exposure on child neurodevelopmental outcomes

Seasonal influenza adapted and evolved during the COVID-19 pandemic

Study reveals how COVID-19 affected the spread and evolution of seasonal influenza

WHO study names top pathogens in need of new vaccines

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Influenza News and Research

Latest Influenza News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in